Cargando…
Effect of Muscle Loss but Not Fat Loss during Primary Debulking Surgery and Chemotherapy on Prognosis of Patients with Ovarian Cancer
Although the negative effect of muscle loss during invasive treatment has been widely reported in patients with cancer, its value in patients with ovarian cancer is not clear. Therefore, this study was conducted to clarify whether muscle loss during cytoreductive surgery and chemotherapy affects pro...
Autores principales: | Nakayama, Naomi, Nakayama, Kentaro, Ishibashi, Tomoka, Katayama, Satoru, Kyo, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181028/ https://www.ncbi.nlm.nih.gov/pubmed/35683568 http://dx.doi.org/10.3390/jcm11113184 |
Ejemplares similares
-
Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas
por: KATAGIRI, HIROSHI, et al.
Publicado: (2015) -
Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced‐stage ovarian cancer
por: Huang, Chueh‐Yi, et al.
Publicado: (2020) -
Ovarian Endometrioid and Clear Cell Carcinomas with Low Prevalence of Microsatellite Instability: A Unique Subset of Ovarian Carcinomas Could Benefit from Combination Therapy with Immune Checkpoint Inhibitors and Other Anticancer Agents
por: Nonomura, Yuki, et al.
Publicado: (2022) -
Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese Patients
por: Sasamori, Hiroki, et al.
Publicado: (2022) -
Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study
por: Razia, Sultana, et al.
Publicado: (2023)